Please login to the form below

Not currently logged in
Email:
Password:

People, July, 2008

Recent high-profiles moves in the pharmaceutical and healthcare industries

Mover of the month

Angus Russell 

Angus Russell has been appointed as the new CEO of UK pharmaceutical company, Shire. He was previously vice-president of corporate finance at AstraZeneca and has experience of tax management, legal, financing structure and investor relations. During his career, he has also worked on group investor relations, strategic planning and marketing management, as well as being a qualified accountant and member of  the Association of Corporate Treasurers.

 

Graham Hetherington, a fellow of the Chartered Institute of Management Accountants, has joined Shire as chief financial officer and executive board director, bringing with him extensive experience of senior financial roles. Outgoing CEO, Matthew Emmens, has also been appointed as chairman and non-executive director. He began his career in the pharmaceutical industry in 1974 and worked his way through various management positions before joining Shire in 2003 as chief executive and member of the board.

Penn Pharmaceutical Services has appointed Ronak Patel as a new formulation scientist. After graduating with a BSc (hons) in pharmaceutical and cosmetic science, Ronak spent a year on a placement with Abbott Laboratories as a formulation scientist, before joining GlaxoSmithKline. He will be working with Penn's formulation development team to produce new and developmental drugs.

Damian Marron has become the new chief executive officer at biopharmaceutical company, Trophos SA. He has extensive experience of corporate development, product and technology licensing, R&D, and sales and marketing. Previously Damian was executive vice-president of corporate development at NicOx SA, where he established collaborations with Merck & Co.

The PM Society has appointed Steve Clark, director of SC Marketing, as its new chairman. He has been actively involved as a committee member for several years and has headed up a number of evening briefings. Steve has also worked with the Prescription Medicines Code of Practice Authority (PMCPA) on the review of the Association of the British Pharmaceutical Industry (ABPI) Code of Practice.

GfK HealthCare has appointed two new members to its team. Mathew Francis has joined as divisional director of the international healthcare team and brings over 12 years' marketing experience from both the client and agency sides of the profession. Prior to taking up his new position with GfK, Mathew was director of the Harris Interactive healthcare team and has also worked for Advanced Medical Optics in Germany. Also joining GfK is Paul O'Shaughnessy who has been appointed as business development director. He has worked for companies such as Thomson Dialog, GE, Decision News Media and AMR Research and has extensive experience of consultancy and research in life sciences.

Tom King has joined Woolley Pau as a copy assistant. After earning a degree in biology, Tom completed an MA in newspaper journalism at the University of Sheffield. He will now begin training as a copywriter.

OgilvyHealthPR has appointed Elizabeth Littlechild as account director. Bringing with her six years' experience in lifestyle, food and nutrition, and consumer health, Elizabeth will work alongside the head of consumer communications to manage a growing portfolio of consumer health brands. Elizabeth has previously worked with clients such as Boots, Braun, Pfizer and Roche.

Laura Maguire has joined Woolley Pau from Torre Lazur McCann as account manager. She has over four years' experience working in both healthcare advertising and medical education.

Insight Research Group has appointed a new member to its team and made two key internal promotions. Jane Barrett joins as a director, Kevin Schou has been promoted to account director and Tom Atkinson has been promoted to director.

Mark Evans joins National Health Intelligence Service (NHIS) as business development manager, bringing 18 years' experience of pharma management information systems.

Resolute Communications has promoted Lisa O'Sullivan to its London senior management team as associate director. She joined the company three years ago as a senior account manager and will provide strategic counsel to its existing global client base. Lisa previously worked for Fleishman-Hillard and OgilvyHealthPR, and has experience of a wide-range of therapeutic areas including oncology, cardiology and neurology. She has dealt with organisations such as the European Society of Cardiology (ESC) and the Global Lung Cancer Coalition.

Lane Earl Cox has made three new appointments to its account handling department. Sara Baynes joins from Pan Advertising as an account director and has experience of therapy areas including anaesthesia, cancer pain and COPD. Sophie Gibbs also joins from Pan Advertising, where she worked on brands used in allergic rhinitis and COPD, along with Uma Thaker who previously worked for Paling Walters with clients including GlaxoSmithKline.

RSA, an executive recruitment specialist in the life sciences sector, has made several key appointments to its team. Kim Spence joins as PA to the chief executive. She previously worked for Pharmacia, where she coordinated UK communications for Nicorette and was the project manager for the Nicorette Yacht. Chantal Williams has joined RSA's executive search manufacturing and quality practice, and Dinesh Chauhan has been appointed as a clinical research and regulatory affairs consultant. Joining the company as an executive search consultant is Noelle Sexton, who has worked in the pharmaceutical industry since 1995. Will Kattell has joined as senior client consultant for RSA Americas and has 10 years' experience of finding senior personnel for the pharmaceutical and medical device industries. Ronja Glorius has been appointed to RSA's offices in Germany as a trainee researcher.

Hajo Riesenbeck is to become chairman of the board for recently merged company, GfK-TNS and Donald Brydon will become the senior independent director of the newly formed firm. David Lowden, who was chief executive of TNS, will retain his title as will Christian Weller von Ahlefeld, who was chief financial officer for GfK.

Debbie Sheppard has joined Skala Marketing and will be responsible for managing existing client accounts as well as contributing to the growth of the firm's client base. She previously worked for Boomerang Media. The company has also appointed James Halliday, an expert in digital brand development and online business processes. James will compliment Skala's existing team of marketing consultants, web designers and creative directors

Red kite consulting has appointed Valérie Brisse-Uhlig as a senior consultant. She has 12 years' sales and marketing experience and has worked with pharmaceutical companies such as Allergan, Schering-Plough Animal Health and Orthofix.

We would like to apologise for the incorrect spelling of Anthea Davies' name in the previous issue. Anthea has been appointed managing director of UK-based branding agency Medicus London. She was previously group account director with the company and has over 20 years' leadership experience within the pharma marketing field. Anthea moved to the agency side of the industry eight years ago.

Policy Matters, has appointed Beverly Evans, Lucy Binding and Sarah Shaw as new partners of the company. Beverly joins from Athena Medical PR, where she was director of the UK business unit. Lucy has been with Policy Matters for six years and Sarah was previously an associate.

Chas Burton, Hillary Carr, Lisa Dodd and Tess Wulff have all been appointed as client service directors at Adventis Health.

 

Related links

FAQ: How do I get my move listed?

 

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics